“Ron brings decades of Manufacturing Operations experience with him into every role. He is always laser focused on driving efficient implementations, believes in rapid decision-making and thrives in high pressure situations. ”
About
Experienced 27 year professional in the Biotech/Pharmaceutical field, experience in a…
Activity
-
Arcellx is now a part of Kite, a Gilead company. Follow Kite Pharma for updates.
Arcellx is now a part of Kite, a Gilead company. Follow Kite Pharma for updates.
Liked by Ron Call
-
Thank you to MGen Whitman for conducting my retirement ceremony after 3 decades of service in the US Marine Corps. What an honor it has been to…
Thank you to MGen Whitman for conducting my retirement ceremony after 3 decades of service in the US Marine Corps. What an honor it has been to…
Liked by Ron Call
Experience
Education
Recommendations received
1 person has recommended Ron
Join now to viewMore activity by Ron
-
I’m proud of the progress reflected in Gilead’s newly released 2025 Responsible Business and Social Impact Report, and especially of the work…
I’m proud of the progress reflected in Gilead’s newly released 2025 Responsible Business and Social Impact Report, and especially of the work…
Liked by Ron Call
-
Every breakthrough is powered by the people who turn possibility into progress, including cell therapy specialists like Kevin Liang. Kevin is…
Every breakthrough is powered by the people who turn possibility into progress, including cell therapy specialists like Kevin Liang. Kevin is…
Liked by Ron Call
-
Yesterday, I said goodbye to my dear colleagues at Kite’s European cell therapy manufacturing site, a place that will always be close to my heart.…
Yesterday, I said goodbye to my dear colleagues at Kite’s European cell therapy manufacturing site, a place that will always be close to my heart.…
Liked by Ron Call
-
We are in Madrid to attend the 52nd Annual Meeting of the EBMT. We look forward to discussing the latest innovations in CAR T-cell therapies and the…
We are in Madrid to attend the 52nd Annual Meeting of the EBMT. We look forward to discussing the latest innovations in CAR T-cell therapies and the…
Liked by Ron Call
-
At Kite, we’re driven by a shared commitment to learning, innovating and making a meaningful difference in patients’ lives. For Mallory McPherson…
At Kite, we’re driven by a shared commitment to learning, innovating and making a meaningful difference in patients’ lives. For Mallory McPherson…
Liked by Ron Call
Explore top content on LinkedIn
Find curated posts and insights for relevant topics all in one place.
View top content